Morgan Stanley upgraded shares of R1 RCM (NASDAQ:RCM – Free Report) from an equal weight rating to an overweight rating in a report released on Friday morning, Marketbeat Ratings reports. The firm currently has $17.00 price target on the healthcare provider’s stock, down from their prior price target of $17.50. Other equities research analysts also […]
JPMorgan Chase & Co. downgraded shares of R1 RCM (NASDAQ:RCM – Free Report) from an overweight rating to a neutral rating in a research note released on Wednesday morning, MarketBeat reports. The brokerage currently has $11.00 price objective on the healthcare provider’s stock, down from their prior price objective of $20.00. A number of other […]
R1 RCM Inc. (NASDAQ:RCM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 1-year price […]